gilead hiv - Search News

News

FDA Approves HIV Shot That’s 99.9% Effective

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

USA TODAY on MSN · 1d

FDA approves new twice-yearly HIV shot. What to know

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

ConsumerAffairs · 11h

FDA approves twice-yearly injection for HIV prevention

FDA Approves Yeztugo as First Twice-Yearly Injectable HIV Prevention Option in the U.S. Clinical Trials Show Near-Perfect Efficacy With 99.9% of Pa

This twice-a-year shot to prevent HIV could stop transmission — if people can get it

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that ...

STAT8h

Pharmalittle: We’re reading about FDA forcing out top gene therapy regulator, Gilead’s HIV challenges and more

And more pharma news updates from Pharmalittle.

Wired14h

The FDA Just Approved a Long-Lasting Injection to Prevent HIV

According to its creator, Gilead Sciences, lenacapavir will be marketed under the trade name Yeztugo. The company has committed to manufacturing 10 million doses by 2026. “This is a historic day in ...

US approves twice-yearly HIV jab in ‘breakthrough moment’ for fight against Aids

The United States has approved a twice-a-year jab that almost entirely protects against HIV in what’s being hailed as a ...

3don MSN

Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern

Gilead Sciences Inc. (NASDAQ:GILD) is one of the 12 best healthcare stocks to buy now. Nevertheless, the company suffered a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results